2019 – Page 14 – Policy & Medicine

Insys $225 Million Settlement and Corporate Integrity Agreement

Idaho Prescription Monitoring Program Monthly Manufacturer Reports for Controlled Substances Due Soon

Update: Econometrica and Open Payments Oversight

Senators Grassley and Wyden Expand Their Opioid Investigation to Tax-Exempt Organizations

Study Shows that Patients’ Out-of-Pocket Costs for Neurology Drugs Have Risen Dramatically In Last 12 Years

FDA Issues Advertising Warning Letter to Vivus

HHS OIG Report: Using Health IT for Care Coordination

The Impact of Open Payments on Oncologists’ Relationships with Industry

FDA to Study Accelerated Approval Drug DTC Marketing

CMS Signals the Use of Mandatory Payment Models if Voluntary Models Don’t Get Enough Participation